AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Palbenz 125 Capsule

Prescription Icon
Prescription Required

Marketer

Admac Pharma Ltd

Salt Composition

Palbociclib (125mg)

Overview Palbenz 125 Capsule

Patients with metastatic, estrogen receptor-positive, HER2-negative breast cancer may be treated with Palbenz 125 Capsules in conjunction with hormonal anticancer therapies. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your individual treatment needs and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under your physician's instruction. Common side effects include tiredness, alopecia, skin rashes, nausea, and diarrhea. Palbenz 125 Capsules can decrease blood cell counts, increasing infection risk. Report any infection symptoms (fever, chills, weakness, bleeding, bruising, epistaxis) to your doctor immediately. Dizziness may occur; avoid driving or activities requiring alertness if affected. Prior to commencing treatment, inform your physician of any pre-existing heart, liver, or kidney conditions, or concurrent use of antimicrobial medications. Interaction with other medications is possible; disclose all current medications to your healthcare provider. This medication is contraindicated during pregnancy and lactation. Reliable contraception is essential for both partners throughout the treatment period to prevent pregnancy.

Uses of Palbenz 125 Capsule

Malignant breast tumor

Major Benefits of Palbenz 125 Capsule:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Palbenz 125 Capsules with food.

Common Side effects of Palbenz 125 Capsule:

  • Decreased blood cells (red cells, white cells, and platelets)
  • Fatigue
  • Hair loss
  • Rash
  • Vomiting
  • Diarrhea
  • Nausea
  • Decreased appetite
  • Infection
  • Decreased white blood cell count
  • Stomatitis (Inflammation of the mouth)
  • Anemia (low number of red blood cells)
  • Weakness
  • Fever

How to use Palbenz 125 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Palbenz 125 Capsules with a meal.

How Palbenz 125 Capsule works:

Palbenz 125 Capsules function as an anti-neoplastic agent. By blocking cyclin-dependent kinases 4 and 6—key proteins in cellular signaling cascades that drive cell growth—it halts the cancerous cell division process. Specifically, it also disrupts the cell cycle in estrogen receptor-positive breast cancers, effectively targeting these types of tumors.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Palbenz 125 Capsules lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Palbenz 125 Capsules during pregnancy poses a confirmed risk to the unborn child and is therefore inadvisable. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the inherent dangers. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Nursing mothers should avoid Palbenz 125 Capsules. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Driving ability may be impaired by Palbenz 125 Capsule, as it can induce fatigue in certain individuals. If this occurs, operating machinery or vehicles requires extra care.

KidneyKidneySAFE IF PRESCRIBED

Palbenz 125 Capsules are considered safe for use in individuals with impaired kidney function. No alteration of the Palbenz 125 Capsule dosage is necessary.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Palbenz 125 Capsules. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Palbenz 125 Capsule :

NA

Facts to Know About Palbenz 125 Capsule

LabelValue
Type of Compound Piperazine-pyridinyl compounds
Addictive None.
Treatment Category Cancer-fighting drugs
Mechanism of Action Cell Cycle Kinase Regulator

FAQs on Palbenz 125 Capsule

The anticancer drug Palbenz 125 Capsule functions by inhibiting cyclin-dependent kinase inhibitors. This inhibition reduces cancer cell proliferation and retards disease advancement.
Treatment length differs individually. The required treatment course will be determined by your physician, considering your health status, treatment response, and tolerability of any adverse effects. Should you experience specific side effects, your doctor may reduce your dosage, temporarily halt, or permanently discontinue your treatment.
The majority of side effects associated with Palbenz 125 Capsule are temporary and resolve upon discontinuation of the medication. A known adverse reaction is neutropenia, characterized by a decrease in white blood cells, leading to compromised immunity and increased infection susceptibility. This effect, however, is typically short-lived and resolves quickly after treatment cessation.
Regular blood monitoring is crucial while taking Palbenz 125 Capsules, as this medication can reduce blood cell levels. These tests assess the drug's impact on white blood cells, red blood cells, and platelets. Blood work is required before each chemotherapy cycle, on day 15 of the initial two cycles, and as deemed medically necessary.
Palbenz 125 Capsule is typically administered once daily for three weeks, followed by a seven-day treatment-free period, completing a full 28-day cycle. Consume the medication with food at the same time each day. Capsules should be swallowed whole; avoid opening, chewing, or crushing them. Discard any damaged or broken capsules. If vomiting occurs after ingestion, refrain from taking a replacement dose and resume the prescribed schedule.
Women capable of becoming pregnant taking Palbenz 125 Capsules, and their partners, must employ reliable contraception (such as dual barrier methods like condoms and diaphragms). This contraception should continue throughout treatment and for a minimum of three weeks post-treatment for women. Male patients using Palbenz 125 Capsules should utilize birth control for at least fourteen weeks following treatment cessation.
Treatment with Palbenz 125 Capsule may impact male reproductive capacity. Therefore, men undergoing this treatment should consider safeguarding their sperm beforehand.
Palbenz 125 Capsule may cause severe adverse reactions such as breathlessness, lightheadedness, fatigue, and abnormal bleeding (including nosebleeds). Fever, shivering, infection indicators, and rapid, erratic, or forceful heartbeats are also potential side effects. Seek immediate medical attention or contact your physician if any of these symptoms develop.
Palbenz 125 Capsule
7,387
MRP 8,999
17% off